We Pharma, INC.
UEI EWAMVJSFNK29 · NC · SAM.gov record ↗
Obligations by agency
- Department Of Health And Human Services$1.9M
Obligations by NAICS
Monthly obligations
Contracts ending within 18 months (recompete watch)
- 75F40125F19011 ↗$300K
PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
- Ends
- Sep 15, 2026
- Started
- Sep 15, 2025
- Agency
- Food And Drug Administration
- NAICS
- 325412
- 75F40125F19010 ↗$75K
PHARMACEUTICAL DRUG PRODUCTS
- Ends
- Nov 12, 2026
- Started
- May 13, 2025
- Agency
- Food And Drug Administration
- NAICS
- 325412
- 75F40125F19004 ↗$1.5M
TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR).
- Ends
- Aug 5, 2027
- Started
- Jul 27, 2025
- Agency
- Food And Drug Administration
- NAICS
- 424210
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75F40125F19011 ↗ | PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES. | Food And Drug Administration | 325412 | $300K | Sep 15, 2025 | Sep 15, 2026 |
| 75F40125F19010 ↗ | PHARMACEUTICAL DRUG PRODUCTS | Food And Drug Administration | 325412 | $75K | May 13, 2025 | Nov 12, 2026 |
| 75F40125F19004 ↗ | TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Food And Drug Administration | 424210 | $1.5M | Jul 27, 2025 | Aug 5, 2027 |
Largest awards
- 75F40125F19004 ↗$1.5M
TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR).
- Ends
- Aug 5, 2027
- Started
- Jul 27, 2025
- Agency
- Food And Drug Administration
- NAICS
- 424210
- 75F40125F19011 ↗$300K
PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES.
- Ends
- Sep 15, 2026
- Started
- Sep 15, 2025
- Agency
- Food And Drug Administration
- NAICS
- 325412
- 75F40125F19010 ↗$75K
PHARMACEUTICAL DRUG PRODUCTS
- Ends
- Nov 12, 2026
- Started
- May 13, 2025
- Agency
- Food And Drug Administration
- NAICS
- 325412
MOD P00002 - TO CORRECT PRIOR FISCAL YEAR FUNDING FROM EACH TO DOLLARS.
- Ends
- Aug 5, 2025
- Started
- Apr 24, 2024
- Agency
- Food And Drug Administration
- NAICS
- 325412
THE CONTRACTOR SHALL PROVIDE THE FDA WITH THE FOLLOWING: I. PRODUCTS LISTED IN ATTACHMENT 1 (PHARMACEUTICAL PRICING LIST), IN RESPONSE TO GOVERNMENT ORDERS. AT A MINIMUM, THIS TABLE WILL BE UPDATED ONCE A YEAR. II. SUPPLY EMERGENCY OVERNIGHT DELI
- Ends
- —
- Started
- Jun 24, 2021
- Agency
- Food And Drug Administration
- NAICS
- 424210
- 75F40118P20106 ↗$-85
PHARMACEUTICAL PRODUCTS
- Ends
- Jul 14, 2020
- Started
- Jun 28, 2018
- Agency
- Food And Drug Administration
- NAICS
- 325412
- 75F40123F19008 ↗$-10K
PHARMACEUTICAL DRUG PRODUCT ORDERS. THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
- Ends
- Aug 5, 2024
- Started
- Jul 30, 2023
- Agency
- Food And Drug Administration
- NAICS
- 325412
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75F40125F19004 ↗ | TO OBTAIN A RELIABLE SOURCE OF CURRENTLY MARKETED DRUG PRODUCTS FOR FDA RESEARCH STUDIES SUPPORTING THE GDUFA REGULATORY SCIENCE PROGRAM, WITHIN THE OFFICE OF PHARMACEUTICAL QUALITY RESEARCH (OPQR). | Food And Drug Administration | 424210 | $1.5M | Jul 27, 2025 | Aug 5, 2027 |
| 75F40125F19011 ↗ | PHARMACEUTICAL DRUG PRODUCTS - TO OBTAIN SOURCE OR SOURCES OF CURRENTLY MARKETED DRUGS PRODUCTS FOR FDA RESEARCH STUDIES. | Food And Drug Administration | 325412 | $300K | Sep 15, 2025 | Sep 15, 2026 |
| 75F40125F19010 ↗ | PHARMACEUTICAL DRUG PRODUCTS | Food And Drug Administration | 325412 | $75K | May 13, 2025 | Nov 12, 2026 |
| 75F40124F19009 ↗ | MOD P00002 - TO CORRECT PRIOR FISCAL YEAR FUNDING FROM EACH TO DOLLARS. | Food And Drug Administration | 325412 | $0 | Apr 24, 2024 | Aug 5, 2025 |
| 75F40121D00018 ↗ | THE CONTRACTOR SHALL PROVIDE THE FDA WITH THE FOLLOWING: I. PRODUCTS LISTED IN ATTACHMENT 1 (PHARMACEUTICAL PRICING LIST), IN RESPONSE TO GOVERNMENT ORDERS. AT A MINIMUM, THIS TABLE WILL BE UPDATED ONCE A YEAR. II. SUPPLY EMERGENCY OVERNIGHT DELI | Food And Drug Administration | 424210 | $0 | Jun 24, 2021 | — |
| 75F40118P20106 ↗ | PHARMACEUTICAL PRODUCTS | Food And Drug Administration | 325412 | $-85 | Jun 28, 2018 | Jul 14, 2020 |
| 75F40123F19008 ↗ | PHARMACEUTICAL DRUG PRODUCT ORDERS. THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT. | Food And Drug Administration | 325412 | $-10K | Jul 30, 2023 | Aug 5, 2024 |